FINWIRES · TerminalLIVE
FINWIRES

RBC Downgrades Telix Pharmaceuticals to Sector Perform From Outperform, Keeps AU$18 Price Target

By

Telix Pharmaceuticals' (TLX) Australian stock has an average rating of buy and mean price target of AU$25.08, according to analysts polled by FactSet.

What else is happening in Research?